Page 1 of Clinical Trials for female contraception, 410 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Evaluation of Women's Experience With EVRA (Norelgestromin + Ethinyl Estradiol) Transdermal Contraceptive Patch Compared With Previous Methods of Contraception.
Last Updated: November 15, 2010
Condition(s): Contraception; Female Contraception
2
Active, not recruiting
A Postmarketing Study of the Risk of Venous Thromboembolism (Blood Clots), Myocardial Infarction (Heart Attacks), and Stroke Among Women Using ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared With Women Who Take Oral Contraceptives for Birth Control
Last Updated: May 18, 2011
Condition(s): Contraception; Female Contraception
3
Completed
A Comparative Pharmacokinetic Study of ORTHO EVRA (a Transdermal Contraceptive Patch) and CILEST (an Oral Contraceptive) in Healthy Female Volunteers
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
4
Completed
An Open-label, Multicentre Study on Preference and Satisfaction of Canadian Women for the Transdermal Contraceptive Patch vs. Previous Primary Contraceptive Method
Last Updated: March 25, 2010
Condition(s): Female Contraception
5
Completed
A Study to Evaluate the Hormone Exposure From Multiple Commercial Lots of ORTHO EVRA (a Transdermal Contraceptive Patch)
Last Updated: June 9, 2011
Condition(s): Contraception; Female Contraception
6
Completed
A Study to Evaluate the Exposure of Norelgestromin and Ethinyl Estradiol From Commercial Lots of EVRA (a Transdermal Contraceptive Patch Manufactured by LOHMANN Therapie-Systeme) and CILEST (an Oral Contraceptive)
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
7
Completed
Bioequivalence Study of the Oral Contraceptive Tablet Containing Norgestimate (NGM)/Ethinyl Estradiol (EE) With or Without Folic Acid in Healthy Women.
Last Updated: June 6, 2011
Condition(s): Female Contraception; Contraception; Therapeutic Equivalency; Pharmacokinetics
8
Active, not recruiting
A Study to Evaluate the Efficacy and Safety of DR-102 for the Prevention of Pregnancy
Last Updated: March 15, 2012
Condition(s): Contraception; Female Contraception
9
Completed
Bioequivalence Study of Patches With Different Equilibration Profiles
Last Updated: June 6, 2011
Condition(s): Female Contraception
10
Completed
Bioequivalence Study of Patches With Different Release Profiles
Last Updated: June 6, 2011
Condition(s): Female Contraception
11
Completed
Relative Risks for Non-Fatal Venous Thromboembolism, Ischemic Stroke and Myocardial Infarction in Users of ORTHO EVRA(Norelgestromin and Ethinyl Estradiol Contraceptive Patch) Compared to Levonorgestrel-Containing Oral Contraceptives.
Last Updated: October 11, 2007
Condition(s): Female Contraception; Contraception; Fertility Control
12
Recruiting
Prevention of Ovulation Achieved by Single Intra-vaginal Administration of Levogel as Compared to Oral LNG
Last Updated: March 15, 2012
Condition(s): Female Contraception
13
Active, not recruiting
Postmarketing Study of ORTHO EVRA (Norelgestromin and Ethinyl Estradiol Contraceptive Patch) in Relation to Venous Thromboembolism (Blood Clots), Stroke and Heart Attacks
Last Updated: May 18, 2011
Condition(s): Contraception; Female Contraception
14
Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System Versus Triphasil.
Last Updated: June 6, 2011
Condition(s): Contraception; Female Contraception
15
Completed
A Study of Efficacy and Safety With the Transdermal Contraceptive System.
Last Updated: November 15, 2010
Condition(s): Contraception; Female Contraception
16
Recruiting
Safety, Tolerability, and Efficacy of ellaOne® (Ulipristal Acetate) for Emergency Contraception in Postmenarcheal Adolescent Girls and Women
Last Updated: March 29, 2012
Condition(s): Contraception
17
Completed
US Ovulation Inhibition Study in Obese Women
Last Updated: May 18, 2012
Condition(s): Contraception
18
Completed
Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)
Last Updated: July 4, 2011
Condition(s): Contraception; Ovulation Inhibition
19
Terminated
Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene
Last Updated: March 1, 2012
Condition(s): Contraception; Ovulation Inhibition
20
Completed
Study Investigating the Efficacy and Safety of a Contraceptive Patch for 13 Cycles
Last Updated: February 13, 2012
Condition(s): Contraception

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=female+contraception

Page 1 of Clinical Trials for female contraception, 410 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About